Skip to main content
. Author manuscript; available in PMC: 2023 Aug 4.
Published in final edited form as: Am Econ J Econ Policy. 2023 Aug;15(3):184–214. doi: 10.1257/pol.20200841

Table 1:

Summary statistics of different samples

(1)
Broad Sample
(2)
Patient Mover Sample
(3)
PCP Exit Sample
Organizational concentration 0.45 (0.27) 0.44 (0.26) 0.46 (0.25)
Provider concentration 0.38 (0.27) 0.36 (0.25) 0.38 (0.24)
Total utilization ($) 8696 (17,649) 8972 (16,239) 7517 (14,144)
Age 75.94 (7.53) 78.48 (7.46) 78.17 (6.96)
Sex: Female 0.58 0.66 0.62
Race: White 0.87 0.90 0.87
Has Diabetes 0.28 0.27 0.36
Has Hypertension 0.61 0.65 0.76
Has Heart disease 0.32 0.34 0.33
N patient-year obs 48,604,598 214,064 304,954
N patients 9,177,819 25,814 51,570
N assigned PCPs 72,231

Notes: This table reports means and then standard deviations in parentheses. Column 1 describes the Broad Sample. Column 2 describes the sample underlying our mover analysis; this sample restricts to patients who move across regions. Column 3 describes the sample underlying our analysis of PCP exits; this sample restricts to patients whose PCP exits the local market. The number of assigned PCPs in column 3 includes exiting PCPs as well as the PCPs patients switched to.